Moreover FLT3-ITD AML models demonstrate increased levels of aerobic glycolysis and similar effects in enhancement of the activity of FLT3 inhibitors can be achieved by glycolysis inhibition (69). Here, FLT3 is linked to acute myeloid leukemia.